Global Infectious Diseases Diagnostic Market 2024 by Company, Regions, Type and Application, Forecast to 2030
![](/report_cover/9988/global-infectious-diseases-diagnostic-market-2019-by-company-regions-type-n-application-forecast-to-2024_en.gif)
According to our (Global Info Research) latest study, the global Infectious Diseases Diagnostic market size was valued at USD 16980 million in 2023 and is forecast to a readjusted size of USD 21390 million by 2030 with a CAGR of 3.3% during review period.
Infectious Diseases Diagnostic is used for confirmation of a disease that can be spreaded in form of a quick, precise test result.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Infectious Diseases Diagnostic industry chain, the market status of Hospitals and Trauma Centers (Urine, Blood), Diagnostic Laboratories (Urine, Blood), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Infectious Diseases Diagnostic.
Regionally, the report analyzes the Infectious Diseases Diagnostic markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Infectious Diseases Diagnostic market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Infectious Diseases Diagnostic market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Infectious Diseases Diagnostic industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Urine, Blood).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Infectious Diseases Diagnostic market.
Regional Analysis: The report involves examining the Infectious Diseases Diagnostic market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Infectious Diseases Diagnostic market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Infectious Diseases Diagnostic:
Company Analysis: Report covers individual Infectious Diseases Diagnostic players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Infectious Diseases Diagnostic This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Trauma Centers, Diagnostic Laboratories).
Technology Analysis: Report covers specific technologies relevant to Infectious Diseases Diagnostic. It assesses the current state, advancements, and potential future developments in Infectious Diseases Diagnostic areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Infectious Diseases Diagnostic market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Infectious Diseases Diagnostic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Infectious Diseases Diagnostic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infectious Diseases Diagnostic, with revenue, gross margin and global market share of Infectious Diseases Diagnostic from 2019 to 2024.
Chapter 3, the Infectious Diseases Diagnostic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Infectious Diseases Diagnostic market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infectious Diseases Diagnostic.
Chapter 13, to describe Infectious Diseases Diagnostic research findings and conclusion.
Infectious Diseases Diagnostic is used for confirmation of a disease that can be spreaded in form of a quick, precise test result.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Infectious Diseases Diagnostic industry chain, the market status of Hospitals and Trauma Centers (Urine, Blood), Diagnostic Laboratories (Urine, Blood), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Infectious Diseases Diagnostic.
Regionally, the report analyzes the Infectious Diseases Diagnostic markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Infectious Diseases Diagnostic market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Infectious Diseases Diagnostic market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Infectious Diseases Diagnostic industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Urine, Blood).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Infectious Diseases Diagnostic market.
Regional Analysis: The report involves examining the Infectious Diseases Diagnostic market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Infectious Diseases Diagnostic market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Infectious Diseases Diagnostic:
Company Analysis: Report covers individual Infectious Diseases Diagnostic players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Infectious Diseases Diagnostic This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Trauma Centers, Diagnostic Laboratories).
Technology Analysis: Report covers specific technologies relevant to Infectious Diseases Diagnostic. It assesses the current state, advancements, and potential future developments in Infectious Diseases Diagnostic areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Infectious Diseases Diagnostic market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Infectious Diseases Diagnostic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Urine
- Blood
- Others
- Hospitals and Trauma Centers
- Diagnostic Laboratories
- Rehabilitation Centers
- Becton Dickinson & Company
- Cepheid, Inc.
- Abbott Laboratories
- bioMerieux SA
- Hologic, Inc.
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Roche Diagnostics
- Alera Inc.
- DiaSorin S.p.A.
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Infectious Diseases Diagnostic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infectious Diseases Diagnostic, with revenue, gross margin and global market share of Infectious Diseases Diagnostic from 2019 to 2024.
Chapter 3, the Infectious Diseases Diagnostic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Infectious Diseases Diagnostic market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infectious Diseases Diagnostic.
Chapter 13, to describe Infectious Diseases Diagnostic research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Infectious Diseases Diagnostic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Infectious Diseases Diagnostic by Type
1.3.1 Overview: Global Infectious Diseases Diagnostic Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Infectious Diseases Diagnostic Consumption Value Market Share by Type in 2023
1.3.3 Urine
1.3.4 Blood
1.3.5 Others
1.4 Global Infectious Diseases Diagnostic Market by Application
1.4.1 Overview: Global Infectious Diseases Diagnostic Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals and Trauma Centers
1.4.3 Diagnostic Laboratories
1.4.4 Rehabilitation Centers
1.5 Global Infectious Diseases Diagnostic Market Size & Forecast
1.6 Global Infectious Diseases Diagnostic Market Size and Forecast by Region
1.6.1 Global Infectious Diseases Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Infectious Diseases Diagnostic Market Size by Region, (2019-2030)
1.6.3 North America Infectious Diseases Diagnostic Market Size and Prospect (2019-2030)
1.6.4 Europe Infectious Diseases Diagnostic Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Infectious Diseases Diagnostic Market Size and Prospect (2019-2030)
1.6.6 South America Infectious Diseases Diagnostic Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Infectious Diseases Diagnostic Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Becton Dickinson & Company
2.1.1 Becton Dickinson & Company Details
2.1.2 Becton Dickinson & Company Major Business
2.1.3 Becton Dickinson & Company Infectious Diseases Diagnostic Product and Solutions
2.1.4 Becton Dickinson & Company Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Becton Dickinson & Company Recent Developments and Future Plans
2.2 Cepheid, Inc.
2.2.1 Cepheid, Inc. Details
2.2.2 Cepheid, Inc. Major Business
2.2.3 Cepheid, Inc. Infectious Diseases Diagnostic Product and Solutions
2.2.4 Cepheid, Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Cepheid, Inc. Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Infectious Diseases Diagnostic Product and Solutions
2.3.4 Abbott Laboratories Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 bioMerieux SA
2.4.1 bioMerieux SA Details
2.4.2 bioMerieux SA Major Business
2.4.3 bioMerieux SA Infectious Diseases Diagnostic Product and Solutions
2.4.4 bioMerieux SA Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 bioMerieux SA Recent Developments and Future Plans
2.5 Hologic, Inc.
2.5.1 Hologic, Inc. Details
2.5.2 Hologic, Inc. Major Business
2.5.3 Hologic, Inc. Infectious Diseases Diagnostic Product and Solutions
2.5.4 Hologic, Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Hologic, Inc. Recent Developments and Future Plans
2.6 Danaher Corporation
2.6.1 Danaher Corporation Details
2.6.2 Danaher Corporation Major Business
2.6.3 Danaher Corporation Infectious Diseases Diagnostic Product and Solutions
2.6.4 Danaher Corporation Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Danaher Corporation Recent Developments and Future Plans
2.7 Thermo Fisher Scientific, Inc.
2.7.1 Thermo Fisher Scientific, Inc. Details
2.7.2 Thermo Fisher Scientific, Inc. Major Business
2.7.3 Thermo Fisher Scientific, Inc. Infectious Diseases Diagnostic Product and Solutions
2.7.4 Thermo Fisher Scientific, Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.8 Roche Diagnostics
2.8.1 Roche Diagnostics Details
2.8.2 Roche Diagnostics Major Business
2.8.3 Roche Diagnostics Infectious Diseases Diagnostic Product and Solutions
2.8.4 Roche Diagnostics Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Roche Diagnostics Recent Developments and Future Plans
2.9 Alera Inc.
2.9.1 Alera Inc. Details
2.9.2 Alera Inc. Major Business
2.9.3 Alera Inc. Infectious Diseases Diagnostic Product and Solutions
2.9.4 Alera Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Alera Inc. Recent Developments and Future Plans
2.10 DiaSorin S.p.A.
2.10.1 DiaSorin S.p.A. Details
2.10.2 DiaSorin S.p.A. Major Business
2.10.3 DiaSorin S.p.A. Infectious Diseases Diagnostic Product and Solutions
2.10.4 DiaSorin S.p.A. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 DiaSorin S.p.A. Recent Developments and Future Plans
2.11 Quidel Corporation
2.11.1 Quidel Corporation Details
2.11.2 Quidel Corporation Major Business
2.11.3 Quidel Corporation Infectious Diseases Diagnostic Product and Solutions
2.11.4 Quidel Corporation Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Quidel Corporation Recent Developments and Future Plans
2.12 Bio-Rad Laboratories, Inc.
2.12.1 Bio-Rad Laboratories, Inc. Details
2.12.2 Bio-Rad Laboratories, Inc. Major Business
2.12.3 Bio-Rad Laboratories, Inc. Infectious Diseases Diagnostic Product and Solutions
2.12.4 Bio-Rad Laboratories, Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Infectious Diseases Diagnostic Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Infectious Diseases Diagnostic by Company Revenue
3.2.2 Top 3 Infectious Diseases Diagnostic Players Market Share in 2023
3.2.3 Top 6 Infectious Diseases Diagnostic Players Market Share in 2023
3.3 Infectious Diseases Diagnostic Market: Overall Company Footprint Analysis
3.3.1 Infectious Diseases Diagnostic Market: Region Footprint
3.3.2 Infectious Diseases Diagnostic Market: Company Product Type Footprint
3.3.3 Infectious Diseases Diagnostic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Infectious Diseases Diagnostic Consumption Value and Market Share by Type (2019-2024)
4.2 Global Infectious Diseases Diagnostic Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Infectious Diseases Diagnostic Consumption Value Market Share by Application (2019-2024)
5.2 Global Infectious Diseases Diagnostic Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Infectious Diseases Diagnostic Consumption Value by Type (2019-2030)
6.2 North America Infectious Diseases Diagnostic Consumption Value by Application (2019-2030)
6.3 North America Infectious Diseases Diagnostic Market Size by Country
6.3.1 North America Infectious Diseases Diagnostic Consumption Value by Country (2019-2030)
6.3.2 United States Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
6.3.3 Canada Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
6.3.4 Mexico Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Infectious Diseases Diagnostic Consumption Value by Type (2019-2030)
7.2 Europe Infectious Diseases Diagnostic Consumption Value by Application (2019-2030)
7.3 Europe Infectious Diseases Diagnostic Market Size by Country
7.3.1 Europe Infectious Diseases Diagnostic Consumption Value by Country (2019-2030)
7.3.2 Germany Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
7.3.3 France Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
7.3.5 Russia Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
7.3.6 Italy Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Infectious Diseases Diagnostic Market Size by Region
8.3.1 Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Region (2019-2030)
8.3.2 China Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
8.3.3 Japan Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
8.3.4 South Korea Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
8.3.5 India Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
8.3.7 Australia Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Infectious Diseases Diagnostic Consumption Value by Type (2019-2030)
9.2 South America Infectious Diseases Diagnostic Consumption Value by Application (2019-2030)
9.3 South America Infectious Diseases Diagnostic Market Size by Country
9.3.1 South America Infectious Diseases Diagnostic Consumption Value by Country (2019-2030)
9.3.2 Brazil Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
9.3.3 Argentina Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Infectious Diseases Diagnostic Market Size by Country
10.3.1 Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Country (2019-2030)
10.3.2 Turkey Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
10.3.4 UAE Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Infectious Diseases Diagnostic Market Drivers
11.2 Infectious Diseases Diagnostic Market Restraints
11.3 Infectious Diseases Diagnostic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Infectious Diseases Diagnostic Industry Chain
12.2 Infectious Diseases Diagnostic Upstream Analysis
12.3 Infectious Diseases Diagnostic Midstream Analysis
12.4 Infectious Diseases Diagnostic Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Infectious Diseases Diagnostic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Infectious Diseases Diagnostic by Type
1.3.1 Overview: Global Infectious Diseases Diagnostic Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Infectious Diseases Diagnostic Consumption Value Market Share by Type in 2023
1.3.3 Urine
1.3.4 Blood
1.3.5 Others
1.4 Global Infectious Diseases Diagnostic Market by Application
1.4.1 Overview: Global Infectious Diseases Diagnostic Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals and Trauma Centers
1.4.3 Diagnostic Laboratories
1.4.4 Rehabilitation Centers
1.5 Global Infectious Diseases Diagnostic Market Size & Forecast
1.6 Global Infectious Diseases Diagnostic Market Size and Forecast by Region
1.6.1 Global Infectious Diseases Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Infectious Diseases Diagnostic Market Size by Region, (2019-2030)
1.6.3 North America Infectious Diseases Diagnostic Market Size and Prospect (2019-2030)
1.6.4 Europe Infectious Diseases Diagnostic Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Infectious Diseases Diagnostic Market Size and Prospect (2019-2030)
1.6.6 South America Infectious Diseases Diagnostic Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Infectious Diseases Diagnostic Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Becton Dickinson & Company
2.1.1 Becton Dickinson & Company Details
2.1.2 Becton Dickinson & Company Major Business
2.1.3 Becton Dickinson & Company Infectious Diseases Diagnostic Product and Solutions
2.1.4 Becton Dickinson & Company Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Becton Dickinson & Company Recent Developments and Future Plans
2.2 Cepheid, Inc.
2.2.1 Cepheid, Inc. Details
2.2.2 Cepheid, Inc. Major Business
2.2.3 Cepheid, Inc. Infectious Diseases Diagnostic Product and Solutions
2.2.4 Cepheid, Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Cepheid, Inc. Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Infectious Diseases Diagnostic Product and Solutions
2.3.4 Abbott Laboratories Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 bioMerieux SA
2.4.1 bioMerieux SA Details
2.4.2 bioMerieux SA Major Business
2.4.3 bioMerieux SA Infectious Diseases Diagnostic Product and Solutions
2.4.4 bioMerieux SA Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 bioMerieux SA Recent Developments and Future Plans
2.5 Hologic, Inc.
2.5.1 Hologic, Inc. Details
2.5.2 Hologic, Inc. Major Business
2.5.3 Hologic, Inc. Infectious Diseases Diagnostic Product and Solutions
2.5.4 Hologic, Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Hologic, Inc. Recent Developments and Future Plans
2.6 Danaher Corporation
2.6.1 Danaher Corporation Details
2.6.2 Danaher Corporation Major Business
2.6.3 Danaher Corporation Infectious Diseases Diagnostic Product and Solutions
2.6.4 Danaher Corporation Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Danaher Corporation Recent Developments and Future Plans
2.7 Thermo Fisher Scientific, Inc.
2.7.1 Thermo Fisher Scientific, Inc. Details
2.7.2 Thermo Fisher Scientific, Inc. Major Business
2.7.3 Thermo Fisher Scientific, Inc. Infectious Diseases Diagnostic Product and Solutions
2.7.4 Thermo Fisher Scientific, Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.8 Roche Diagnostics
2.8.1 Roche Diagnostics Details
2.8.2 Roche Diagnostics Major Business
2.8.3 Roche Diagnostics Infectious Diseases Diagnostic Product and Solutions
2.8.4 Roche Diagnostics Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Roche Diagnostics Recent Developments and Future Plans
2.9 Alera Inc.
2.9.1 Alera Inc. Details
2.9.2 Alera Inc. Major Business
2.9.3 Alera Inc. Infectious Diseases Diagnostic Product and Solutions
2.9.4 Alera Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Alera Inc. Recent Developments and Future Plans
2.10 DiaSorin S.p.A.
2.10.1 DiaSorin S.p.A. Details
2.10.2 DiaSorin S.p.A. Major Business
2.10.3 DiaSorin S.p.A. Infectious Diseases Diagnostic Product and Solutions
2.10.4 DiaSorin S.p.A. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 DiaSorin S.p.A. Recent Developments and Future Plans
2.11 Quidel Corporation
2.11.1 Quidel Corporation Details
2.11.2 Quidel Corporation Major Business
2.11.3 Quidel Corporation Infectious Diseases Diagnostic Product and Solutions
2.11.4 Quidel Corporation Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Quidel Corporation Recent Developments and Future Plans
2.12 Bio-Rad Laboratories, Inc.
2.12.1 Bio-Rad Laboratories, Inc. Details
2.12.2 Bio-Rad Laboratories, Inc. Major Business
2.12.3 Bio-Rad Laboratories, Inc. Infectious Diseases Diagnostic Product and Solutions
2.12.4 Bio-Rad Laboratories, Inc. Infectious Diseases Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Infectious Diseases Diagnostic Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Infectious Diseases Diagnostic by Company Revenue
3.2.2 Top 3 Infectious Diseases Diagnostic Players Market Share in 2023
3.2.3 Top 6 Infectious Diseases Diagnostic Players Market Share in 2023
3.3 Infectious Diseases Diagnostic Market: Overall Company Footprint Analysis
3.3.1 Infectious Diseases Diagnostic Market: Region Footprint
3.3.2 Infectious Diseases Diagnostic Market: Company Product Type Footprint
3.3.3 Infectious Diseases Diagnostic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Infectious Diseases Diagnostic Consumption Value and Market Share by Type (2019-2024)
4.2 Global Infectious Diseases Diagnostic Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Infectious Diseases Diagnostic Consumption Value Market Share by Application (2019-2024)
5.2 Global Infectious Diseases Diagnostic Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Infectious Diseases Diagnostic Consumption Value by Type (2019-2030)
6.2 North America Infectious Diseases Diagnostic Consumption Value by Application (2019-2030)
6.3 North America Infectious Diseases Diagnostic Market Size by Country
6.3.1 North America Infectious Diseases Diagnostic Consumption Value by Country (2019-2030)
6.3.2 United States Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
6.3.3 Canada Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
6.3.4 Mexico Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Infectious Diseases Diagnostic Consumption Value by Type (2019-2030)
7.2 Europe Infectious Diseases Diagnostic Consumption Value by Application (2019-2030)
7.3 Europe Infectious Diseases Diagnostic Market Size by Country
7.3.1 Europe Infectious Diseases Diagnostic Consumption Value by Country (2019-2030)
7.3.2 Germany Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
7.3.3 France Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
7.3.5 Russia Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
7.3.6 Italy Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Infectious Diseases Diagnostic Market Size by Region
8.3.1 Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Region (2019-2030)
8.3.2 China Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
8.3.3 Japan Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
8.3.4 South Korea Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
8.3.5 India Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
8.3.7 Australia Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Infectious Diseases Diagnostic Consumption Value by Type (2019-2030)
9.2 South America Infectious Diseases Diagnostic Consumption Value by Application (2019-2030)
9.3 South America Infectious Diseases Diagnostic Market Size by Country
9.3.1 South America Infectious Diseases Diagnostic Consumption Value by Country (2019-2030)
9.3.2 Brazil Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
9.3.3 Argentina Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Infectious Diseases Diagnostic Market Size by Country
10.3.1 Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Country (2019-2030)
10.3.2 Turkey Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
10.3.4 UAE Infectious Diseases Diagnostic Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Infectious Diseases Diagnostic Market Drivers
11.2 Infectious Diseases Diagnostic Market Restraints
11.3 Infectious Diseases Diagnostic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Infectious Diseases Diagnostic Industry Chain
12.2 Infectious Diseases Diagnostic Upstream Analysis
12.3 Infectious Diseases Diagnostic Midstream Analysis
12.4 Infectious Diseases Diagnostic Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Infectious Diseases Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Infectious Diseases Diagnostic Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Infectious Diseases Diagnostic Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Infectious Diseases Diagnostic Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Becton Dickinson & Company Company Information, Head Office, and Major Competitors
Table 6. Becton Dickinson & Company Major Business
Table 7. Becton Dickinson & Company Infectious Diseases Diagnostic Product and Solutions
Table 8. Becton Dickinson & Company Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Becton Dickinson & Company Recent Developments and Future Plans
Table 10. Cepheid, Inc. Company Information, Head Office, and Major Competitors
Table 11. Cepheid, Inc. Major Business
Table 12. Cepheid, Inc. Infectious Diseases Diagnostic Product and Solutions
Table 13. Cepheid, Inc. Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Cepheid, Inc. Recent Developments and Future Plans
Table 15. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 16. Abbott Laboratories Major Business
Table 17. Abbott Laboratories Infectious Diseases Diagnostic Product and Solutions
Table 18. Abbott Laboratories Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Abbott Laboratories Recent Developments and Future Plans
Table 20. bioMerieux SA Company Information, Head Office, and Major Competitors
Table 21. bioMerieux SA Major Business
Table 22. bioMerieux SA Infectious Diseases Diagnostic Product and Solutions
Table 23. bioMerieux SA Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. bioMerieux SA Recent Developments and Future Plans
Table 25. Hologic, Inc. Company Information, Head Office, and Major Competitors
Table 26. Hologic, Inc. Major Business
Table 27. Hologic, Inc. Infectious Diseases Diagnostic Product and Solutions
Table 28. Hologic, Inc. Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Hologic, Inc. Recent Developments and Future Plans
Table 30. Danaher Corporation Company Information, Head Office, and Major Competitors
Table 31. Danaher Corporation Major Business
Table 32. Danaher Corporation Infectious Diseases Diagnostic Product and Solutions
Table 33. Danaher Corporation Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Danaher Corporation Recent Developments and Future Plans
Table 35. Thermo Fisher Scientific, Inc. Company Information, Head Office, and Major Competitors
Table 36. Thermo Fisher Scientific, Inc. Major Business
Table 37. Thermo Fisher Scientific, Inc. Infectious Diseases Diagnostic Product and Solutions
Table 38. Thermo Fisher Scientific, Inc. Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
Table 40. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 41. Roche Diagnostics Major Business
Table 42. Roche Diagnostics Infectious Diseases Diagnostic Product and Solutions
Table 43. Roche Diagnostics Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Roche Diagnostics Recent Developments and Future Plans
Table 45. Alera Inc. Company Information, Head Office, and Major Competitors
Table 46. Alera Inc. Major Business
Table 47. Alera Inc. Infectious Diseases Diagnostic Product and Solutions
Table 48. Alera Inc. Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Alera Inc. Recent Developments and Future Plans
Table 50. DiaSorin S.p.A. Company Information, Head Office, and Major Competitors
Table 51. DiaSorin S.p.A. Major Business
Table 52. DiaSorin S.p.A. Infectious Diseases Diagnostic Product and Solutions
Table 53. DiaSorin S.p.A. Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. DiaSorin S.p.A. Recent Developments and Future Plans
Table 55. Quidel Corporation Company Information, Head Office, and Major Competitors
Table 56. Quidel Corporation Major Business
Table 57. Quidel Corporation Infectious Diseases Diagnostic Product and Solutions
Table 58. Quidel Corporation Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Quidel Corporation Recent Developments and Future Plans
Table 60. Bio-Rad Laboratories, Inc. Company Information, Head Office, and Major Competitors
Table 61. Bio-Rad Laboratories, Inc. Major Business
Table 62. Bio-Rad Laboratories, Inc. Infectious Diseases Diagnostic Product and Solutions
Table 63. Bio-Rad Laboratories, Inc. Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
Table 65. Global Infectious Diseases Diagnostic Revenue (USD Million) by Players (2019-2024)
Table 66. Global Infectious Diseases Diagnostic Revenue Share by Players (2019-2024)
Table 67. Breakdown of Infectious Diseases Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Infectious Diseases Diagnostic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key Infectious Diseases Diagnostic Players
Table 70. Infectious Diseases Diagnostic Market: Company Product Type Footprint
Table 71. Infectious Diseases Diagnostic Market: Company Product Application Footprint
Table 72. Infectious Diseases Diagnostic New Market Entrants and Barriers to Market Entry
Table 73. Infectious Diseases Diagnostic Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Infectious Diseases Diagnostic Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global Infectious Diseases Diagnostic Consumption Value Share by Type (2019-2024)
Table 76. Global Infectious Diseases Diagnostic Consumption Value Forecast by Type (2025-2030)
Table 77. Global Infectious Diseases Diagnostic Consumption Value by Application (2019-2024)
Table 78. Global Infectious Diseases Diagnostic Consumption Value Forecast by Application (2025-2030)
Table 79. North America Infectious Diseases Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America Infectious Diseases Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America Infectious Diseases Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 82. North America Infectious Diseases Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 83. North America Infectious Diseases Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America Infectious Diseases Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe Infectious Diseases Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe Infectious Diseases Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe Infectious Diseases Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Europe Infectious Diseases Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Europe Infectious Diseases Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Infectious Diseases Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 94. Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 95. Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America Infectious Diseases Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America Infectious Diseases Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America Infectious Diseases Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 100. South America Infectious Diseases Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 101. South America Infectious Diseases Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America Infectious Diseases Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 106. Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 107. Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 109. Infectious Diseases Diagnostic Raw Material
Table 110. Key Suppliers of Infectious Diseases Diagnostic Raw Materials
Table 1. Global Infectious Diseases Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Infectious Diseases Diagnostic Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Infectious Diseases Diagnostic Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Infectious Diseases Diagnostic Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Becton Dickinson & Company Company Information, Head Office, and Major Competitors
Table 6. Becton Dickinson & Company Major Business
Table 7. Becton Dickinson & Company Infectious Diseases Diagnostic Product and Solutions
Table 8. Becton Dickinson & Company Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Becton Dickinson & Company Recent Developments and Future Plans
Table 10. Cepheid, Inc. Company Information, Head Office, and Major Competitors
Table 11. Cepheid, Inc. Major Business
Table 12. Cepheid, Inc. Infectious Diseases Diagnostic Product and Solutions
Table 13. Cepheid, Inc. Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Cepheid, Inc. Recent Developments and Future Plans
Table 15. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 16. Abbott Laboratories Major Business
Table 17. Abbott Laboratories Infectious Diseases Diagnostic Product and Solutions
Table 18. Abbott Laboratories Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Abbott Laboratories Recent Developments and Future Plans
Table 20. bioMerieux SA Company Information, Head Office, and Major Competitors
Table 21. bioMerieux SA Major Business
Table 22. bioMerieux SA Infectious Diseases Diagnostic Product and Solutions
Table 23. bioMerieux SA Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. bioMerieux SA Recent Developments and Future Plans
Table 25. Hologic, Inc. Company Information, Head Office, and Major Competitors
Table 26. Hologic, Inc. Major Business
Table 27. Hologic, Inc. Infectious Diseases Diagnostic Product and Solutions
Table 28. Hologic, Inc. Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Hologic, Inc. Recent Developments and Future Plans
Table 30. Danaher Corporation Company Information, Head Office, and Major Competitors
Table 31. Danaher Corporation Major Business
Table 32. Danaher Corporation Infectious Diseases Diagnostic Product and Solutions
Table 33. Danaher Corporation Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Danaher Corporation Recent Developments and Future Plans
Table 35. Thermo Fisher Scientific, Inc. Company Information, Head Office, and Major Competitors
Table 36. Thermo Fisher Scientific, Inc. Major Business
Table 37. Thermo Fisher Scientific, Inc. Infectious Diseases Diagnostic Product and Solutions
Table 38. Thermo Fisher Scientific, Inc. Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
Table 40. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 41. Roche Diagnostics Major Business
Table 42. Roche Diagnostics Infectious Diseases Diagnostic Product and Solutions
Table 43. Roche Diagnostics Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Roche Diagnostics Recent Developments and Future Plans
Table 45. Alera Inc. Company Information, Head Office, and Major Competitors
Table 46. Alera Inc. Major Business
Table 47. Alera Inc. Infectious Diseases Diagnostic Product and Solutions
Table 48. Alera Inc. Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Alera Inc. Recent Developments and Future Plans
Table 50. DiaSorin S.p.A. Company Information, Head Office, and Major Competitors
Table 51. DiaSorin S.p.A. Major Business
Table 52. DiaSorin S.p.A. Infectious Diseases Diagnostic Product and Solutions
Table 53. DiaSorin S.p.A. Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. DiaSorin S.p.A. Recent Developments and Future Plans
Table 55. Quidel Corporation Company Information, Head Office, and Major Competitors
Table 56. Quidel Corporation Major Business
Table 57. Quidel Corporation Infectious Diseases Diagnostic Product and Solutions
Table 58. Quidel Corporation Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Quidel Corporation Recent Developments and Future Plans
Table 60. Bio-Rad Laboratories, Inc. Company Information, Head Office, and Major Competitors
Table 61. Bio-Rad Laboratories, Inc. Major Business
Table 62. Bio-Rad Laboratories, Inc. Infectious Diseases Diagnostic Product and Solutions
Table 63. Bio-Rad Laboratories, Inc. Infectious Diseases Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
Table 65. Global Infectious Diseases Diagnostic Revenue (USD Million) by Players (2019-2024)
Table 66. Global Infectious Diseases Diagnostic Revenue Share by Players (2019-2024)
Table 67. Breakdown of Infectious Diseases Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Infectious Diseases Diagnostic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key Infectious Diseases Diagnostic Players
Table 70. Infectious Diseases Diagnostic Market: Company Product Type Footprint
Table 71. Infectious Diseases Diagnostic Market: Company Product Application Footprint
Table 72. Infectious Diseases Diagnostic New Market Entrants and Barriers to Market Entry
Table 73. Infectious Diseases Diagnostic Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Infectious Diseases Diagnostic Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global Infectious Diseases Diagnostic Consumption Value Share by Type (2019-2024)
Table 76. Global Infectious Diseases Diagnostic Consumption Value Forecast by Type (2025-2030)
Table 77. Global Infectious Diseases Diagnostic Consumption Value by Application (2019-2024)
Table 78. Global Infectious Diseases Diagnostic Consumption Value Forecast by Application (2025-2030)
Table 79. North America Infectious Diseases Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America Infectious Diseases Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America Infectious Diseases Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 82. North America Infectious Diseases Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 83. North America Infectious Diseases Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America Infectious Diseases Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe Infectious Diseases Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe Infectious Diseases Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe Infectious Diseases Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Europe Infectious Diseases Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Europe Infectious Diseases Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Infectious Diseases Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 94. Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 95. Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific Infectious Diseases Diagnostic Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America Infectious Diseases Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America Infectious Diseases Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America Infectious Diseases Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 100. South America Infectious Diseases Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 101. South America Infectious Diseases Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America Infectious Diseases Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Application (2019-2024) & (USD Million)
Table 106. Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Application (2025-2030) & (USD Million)
Table 107. Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa Infectious Diseases Diagnostic Consumption Value by Country (2025-2030) & (USD Million)
Table 109. Infectious Diseases Diagnostic Raw Material
Table 110. Key Suppliers of Infectious Diseases Diagnostic Raw Materials
LIST OF FIGURES
Figure 1. Infectious Diseases Diagnostic Picture
Figure 2. Global Infectious Diseases Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Infectious Diseases Diagnostic Consumption Value Market Share by Type in 2023
Figure 4. Urine
Figure 5. Blood
Figure 6. Others
Figure 7. Global Infectious Diseases Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Infectious Diseases Diagnostic Consumption Value Market Share by Application in 2023
Figure 9. Hospitals and Trauma Centers Picture
Figure 10. Diagnostic Laboratories Picture
Figure 11. Rehabilitation Centers Picture
Figure 12. Global Infectious Diseases Diagnostic Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Infectious Diseases Diagnostic Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Infectious Diseases Diagnostic Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Infectious Diseases Diagnostic Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Infectious Diseases Diagnostic Consumption Value Market Share by Region in 2023
Figure 17. North America Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Infectious Diseases Diagnostic Revenue Share by Players in 2023
Figure 23. Infectious Diseases Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Infectious Diseases Diagnostic Market Share in 2023
Figure 25. Global Top 6 Players Infectious Diseases Diagnostic Market Share in 2023
Figure 26. Global Infectious Diseases Diagnostic Consumption Value Share by Type (2019-2024)
Figure 27. Global Infectious Diseases Diagnostic Market Share Forecast by Type (2025-2030)
Figure 28. Global Infectious Diseases Diagnostic Consumption Value Share by Application (2019-2024)
Figure 29. Global Infectious Diseases Diagnostic Market Share Forecast by Application (2025-2030)
Figure 30. North America Infectious Diseases Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Infectious Diseases Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Infectious Diseases Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Infectious Diseases Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Infectious Diseases Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Infectious Diseases Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 40. France Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Infectious Diseases Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Infectious Diseases Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Infectious Diseases Diagnostic Consumption Value Market Share by Region (2019-2030)
Figure 47. China Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 50. India Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Infectious Diseases Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Infectious Diseases Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Infectious Diseases Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Infectious Diseases Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Infectious Diseases Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Infectious Diseases Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 64. Infectious Diseases Diagnostic Market Drivers
Figure 65. Infectious Diseases Diagnostic Market Restraints
Figure 66. Infectious Diseases Diagnostic Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Infectious Diseases Diagnostic in 2023
Figure 69. Manufacturing Process Analysis of Infectious Diseases Diagnostic
Figure 70. Infectious Diseases Diagnostic Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Infectious Diseases Diagnostic Picture
Figure 2. Global Infectious Diseases Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Infectious Diseases Diagnostic Consumption Value Market Share by Type in 2023
Figure 4. Urine
Figure 5. Blood
Figure 6. Others
Figure 7. Global Infectious Diseases Diagnostic Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Infectious Diseases Diagnostic Consumption Value Market Share by Application in 2023
Figure 9. Hospitals and Trauma Centers Picture
Figure 10. Diagnostic Laboratories Picture
Figure 11. Rehabilitation Centers Picture
Figure 12. Global Infectious Diseases Diagnostic Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Infectious Diseases Diagnostic Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Infectious Diseases Diagnostic Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Infectious Diseases Diagnostic Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Infectious Diseases Diagnostic Consumption Value Market Share by Region in 2023
Figure 17. North America Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Infectious Diseases Diagnostic Revenue Share by Players in 2023
Figure 23. Infectious Diseases Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Infectious Diseases Diagnostic Market Share in 2023
Figure 25. Global Top 6 Players Infectious Diseases Diagnostic Market Share in 2023
Figure 26. Global Infectious Diseases Diagnostic Consumption Value Share by Type (2019-2024)
Figure 27. Global Infectious Diseases Diagnostic Market Share Forecast by Type (2025-2030)
Figure 28. Global Infectious Diseases Diagnostic Consumption Value Share by Application (2019-2024)
Figure 29. Global Infectious Diseases Diagnostic Market Share Forecast by Application (2025-2030)
Figure 30. North America Infectious Diseases Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Infectious Diseases Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Infectious Diseases Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Infectious Diseases Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Infectious Diseases Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Infectious Diseases Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 40. France Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Infectious Diseases Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Infectious Diseases Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Infectious Diseases Diagnostic Consumption Value Market Share by Region (2019-2030)
Figure 47. China Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 50. India Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Infectious Diseases Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Infectious Diseases Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Infectious Diseases Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Infectious Diseases Diagnostic Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Infectious Diseases Diagnostic Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Infectious Diseases Diagnostic Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Infectious Diseases Diagnostic Consumption Value (2019-2030) & (USD Million)
Figure 64. Infectious Diseases Diagnostic Market Drivers
Figure 65. Infectious Diseases Diagnostic Market Restraints
Figure 66. Infectious Diseases Diagnostic Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Infectious Diseases Diagnostic in 2023
Figure 69. Manufacturing Process Analysis of Infectious Diseases Diagnostic
Figure 70. Infectious Diseases Diagnostic Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source